Navigation Links
BioStorage Technologies Appoints New Member to Board of Directors
Date:12/8/2011

INDIANAPOLIS, Dec. 8, 2011 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions including consulting, storage, cold chain logistics and virtual sample intelligence and tracking for the bioscience industry, announced today that Thomas J. Newman, M.D., has been appointed to the company's board of directors. Dr. Newman joins BioStorage Technologies with more than 30 years of executive and leadership experience in the contract services and pharmaceutical industries.

"We are pleased to have an industry expert of Dr. Newman's caliber as a member of our board and are certain that he will provide significant contributions to the shared vision for BioStorage Technologies' growth and market expansion next year and beyond," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "His vast amount of experience in contract services will only add to our boards' already extensive knowledge of the pharmaceutical industry."

Most recently, Dr. Newman served as President of PharmaNet Development Group, a global drug development services company, where he was responsible for worldwide operations. He also served in various capacities of executive leadership at Covance and Bristol-Myers Squibb. Prior to joining industry he was on the faculty of the Department of Pediatrics at the University of Minnesota Medical School.

Dr. Newman received his M.D. from Tufts University School of Medicine and his Bachelor of Arts degree in biology from Cornell University.

About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
2. BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility
3. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
4. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
5. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
8. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
9. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
10. BioStorage Technologies Appoints New Vice President of Global Sales
11. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):